<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00449826</url>
  </required_header>
  <id_info>
    <org_study_id>UOHI 2006361-01H</org_study_id>
    <nct_id>NCT00449826</nct_id>
  </id_info>
  <brief_title>Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)</brief_title>
  <official_title>Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Heart Institute Research Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of this project is to examine the effectiveness of computed tomographic&#xD;
      angiography (CTA) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).&#xD;
      People who are hospitalized with this situation often require an angiogram to assess the&#xD;
      heart and its arteries.&#xD;
&#xD;
      Recent advancements in technology have enabled CTA to clearly define coronary artery anatomy&#xD;
      with great accuracy and to guide treatment strategies in select patient populations. We are&#xD;
      investigating that CTA may be used, as an alternative to conventional angiograms, for the&#xD;
      risk stratification of patients with high risk NSTE-ACS.&#xD;
&#xD;
      Patients eligible for the study will be high risk NSTE-ACS and awaiting an angiogram.&#xD;
      Enrolled patients will undergo CTA prior to the angiogram. With each CTA the patient will be&#xD;
      injected with a small dose of an X-ray dye and will be asked to lie still on the &quot;scanning&#xD;
      bed&quot; for a period of 5-10 minutes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operating Characteristics of CTA</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the accuracy of CTA to CICA in predicting the mode of revascularization (PCI versus CABG) in NSTE-ACS patients.</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the number of &quot;avoidable&quot; CICA (i.e. those accurately designated to medical therapy or surgery with CTA).</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">107</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Non-ST-Elevation Myocardial Infarction</condition>
  <condition>Unstable Angina</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Computed Tomographic Angiography</intervention_name>
    <description>CT scan</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  High risk ACS&#xD;
&#xD;
               1. Angina [accelerating pattern or prolonged episode (&gt; 20 minutes) or recurrent&#xD;
                  episode at rest or with minimal effort within preceding 24 hours]; and (13)&#xD;
&#xD;
               2. Elevated Troponin - T (≥0.1 ug/L) or ECG changes consistent with ischemia [ST&#xD;
                  depression ≥ 0.1 mV, transient ST segment elevation ≥ 0.1 mV (&lt; 20 minutes)])&#xD;
                  (11;13)&#xD;
&#xD;
          -  Planned conventional invasive coronary angiography&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years or lack of consent&#xD;
&#xD;
          -  Renal Insufficiency (GFR &lt; 60 ml/min)&#xD;
&#xD;
          -  Allergy to contrast agent&#xD;
&#xD;
          -  Refractory angina requiring urgent/emergent coronary angiography (as per treating&#xD;
             physician)&#xD;
&#xD;
          -  Contraindication to radiation exposure (e.g. pregnancy)&#xD;
&#xD;
          -  Uncontrolled HR&#xD;
&#xD;
          -  Previous CABG or PCI/Stent&#xD;
&#xD;
          -  Atrial fibrillation, frequent atrial or ventricular ectopy (&gt; 1 / minute)&#xD;
&#xD;
          -  Unable to perform 20 second breath-hold&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole Dennie, MD</last_name>
    <role>Study Director</role>
    <affiliation>The Ottawa Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Derek So, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Glvoer, MD</last_name>
    <role>Study Director</role>
    <affiliation>Univeristy of Ottawa Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benjamin JW Chow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.ottawaheart.ca</url>
    <description>University of Ottawa Heart Institute</description>
  </link>
  <verification_date>January 2012</verification_date>
  <study_first_submitted>March 20, 2007</study_first_submitted>
  <study_first_submitted_qc>March 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2007</study_first_posted>
  <last_update_submitted>January 25, 2012</last_update_submitted>
  <last_update_submitted_qc>January 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ottawa Heart Institute Research Corporation</investigator_affiliation>
    <investigator_full_name>Benjamin Chow</investigator_full_name>
    <investigator_title>Dr Benjamin Chow</investigator_title>
  </responsible_party>
  <keyword>ACS</keyword>
  <keyword>Unstable Angina</keyword>
  <keyword>NSTEMI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

